Tang Huadong, Mayersohn Michael
Department of Pharmaceutical Sciences, College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA.
Drug Metab Dispos. 2005 Sep;33(9):1288-93. doi: 10.1124/dmd.105.004127. Epub 2005 May 26.
A general equation was derived, which directly describes the mathematical relationship between the allometrically predicted pharmacokinetic (PK) parameters in humans and the body weights of animal species (along with their corresponding measured PK parameters). It was shown, with use of the derived equation, that the predicted values in humans, based on combinations of animal species commonly used in allometry, are heavily dependent on certain species, for example, the dog. In contrast, parameter values from the rat made no contribution to the predicted human values, as long as the rat was not the smallest species used. Monte Carlo simulations were further performed to examine the species or weight dependence. The cost-effective combinations of animal species, in terms of number and species type, were theoretically examined through simulations. Finally, literature data demonstrated the species or weight dependence predicted from the equation and as illustrated through the Monte Carlo simulations. Appreciation of this species or weight dependence should guide researchers in selecting animal species and designing optimal experiments in the application of allometric scaling.
推导了一个通用方程,该方程直接描述了人体中异速生长预测的药代动力学(PK)参数与动物物种体重(以及它们相应的实测PK参数)之间的数学关系。利用推导的方程表明,基于异速生长中常用动物物种的组合,人体中的预测值严重依赖于某些物种,例如狗。相比之下,只要大鼠不是所使用的最小物种,大鼠的参数值对预测的人体值就没有贡献。进一步进行了蒙特卡洛模拟以检验物种或体重依赖性。通过模拟从理论上研究了在数量和物种类型方面具有成本效益的动物物种组合。最后,文献数据证明了从方程预测并通过蒙特卡洛模拟说明的物种或体重依赖性。认识到这种物种或体重依赖性应指导研究人员在应用异速生长标度时选择动物物种并设计最佳实验。